Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 503181 - 503200 out of 504621 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EF01) palbociclib (adm: O) | IBRANCE 125MG TAB,ORAL 3X7 U/D | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01EF01) palbociclib (adm: O) | IBRANCE 75MG TAB,ORAL 3X7 U/D | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01EF01) palbociclib (adm: O) | IBRANCE 75MG TAB,ORAL 3X7 U/D | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PfizerInc. |
| USA | (L01EG01) temsirolimus (adm: P) | TORISEL 25MG/ML INJ 1.8ML,VIAL | 1.8ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Lymphoma, Mantle-Cell | PfizerInc. |
| USA | (L01EG01) temsirolimus (adm: P) | TORISEL 25MG/ML INJ 1.8ML,VIAL | 1.8ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Lymphoma, Mantle-Cell | PfizerInc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 150MG TABLET | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | PfizerInc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 150MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | PfizerInc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 150MG TABLET | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | PfizerInc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 150MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | PfizerInc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 50MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | PfizerInc. |
| USA | (L01EH03) tucatinib (adm: O) | TUKYSA 50MG TABLET | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms;Neoplasm Metastasis | PfizerInc. |
| USA | (L01EK01) axitinib (adm: O) | INLYTA 1 MG TAB | 180 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | PfizerInc. |
| USA | (L01EK01) axitinib (adm: O) | INLYTA 1 MG TAB | 180 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | PfizerInc. |
| USA | (L01EK01) axitinib (adm: O) | INLYTA 5MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | PfizerInc. |
| USA | (L01EK01) axitinib (adm: O) | INLYTA 5MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | PfizerInc. |
| USA | (L01EK04) fruquintinib | FRUZAQLA 1MG CAP,ORAL | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L01EK04) fruquintinib | FRUZAQLA 1MG CAP,ORAL | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L01EK04) fruquintinib | FRUZAQLA 5MG CAP,ORAL | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L01EK04) fruquintinib | FRUZAQLA 5MG CAP,ORAL | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L01EL01) ibrutinib (adm: O) | IBRUTINIB 70MG/ML SUSP,ORAL | 108ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Pharmacyclics,LLC |
Pages
